- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02679833
Effect of Toothpaste Fortified With Cyanocobalamin on Vitamin B12 Status
May 7, 2018 updated by: Rima Obeid, Universität des Saarlandes
Effect of Toothpaste Fortified With Cyanocobalamin on Vitamin B12 Status: A 3 Month Placebo Controlled Randomized Study
A 3 months randomized, placebo-controlled study on the effect of toothpaste fortified with vitamin B12 on vitamin B12 status markers and related metabolic markers.
The primary outcome variable is the difference in the change of methylmalonic acid after 3 months between the two study arms.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
180
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Giessen, Germany, 35444
- Institute of Alternative and Sustainable Nutrition
-
-
Saarland
-
Homburg, Saarland, Germany, 66421
- University of Saarland
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults: men and women
- Stable diet for at least 24 months (omnivorous or a vegan diet).
Exclusion Criteria:
- Pregnancy and lactation
- Malabsorption disorders (Crohn disease, chronic gastritis, pernicious anemia, gastric or intestinal resection)
- Renal diseases
- Liver diseases
- Patients with cancer (or cancer history)
- Pre-study treatment with vitamin B12 or folate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
A toothpaste, with the same matrix, all components, and appearance like the active arm but not containing vitamin B12.
|
Toothpaste not containing the vitamin.
|
|
Active Comparator: Cyanocobalamin
A toothpaste with cyanocobalamin 100 µg cyanocobalamin per 1 g.
|
Toothpaste containing100 µg cyanocobalamin/g.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change in plasma concentrations of methylmalonic acid
Time Frame: Baseline, 3 months
|
Lowering methylmalonic acid in the B12 arm compared with the placebo arm
|
Baseline, 3 months
|
|
The change in plasma concentrations of holotranscobalamin
Time Frame: Baseline, 3 months
|
The effect on increasing holotranscobalamin in the B12 arm compared with the placebo arm
|
Baseline, 3 months
|
|
The change in plasma concentrations of homocysteine
Time Frame: Baseline, 3 months
|
Lowering homocysteine in the B12 arm compared with the placebo arm
|
Baseline, 3 months
|
|
The change in plasma concentrations of vitamin B12
Time Frame: Baseline, 3 months
|
The effect on increasing plasma vitamin B12 in the B12 arm compared with the placebo arm
|
Baseline, 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Markus Keller, PhD, Institute of Alternative and Sustainable Nutrition, Giessen, Germany
- Study Director: Rima Obeid, PhD, Saarland University Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Zant A, Awwad HM, Geisel J, Keller M, Obeid R. Vitamin B12-fortified toothpaste improves vitamin status in elderly people: a randomized, double-blind, placebo-controlled study. Aging Clin Exp Res. 2019 Dec;31(12):1817-1825. doi: 10.1007/s40520-019-01125-6. Epub 2019 Jan 24.
- Siebert AK, Obeid R, Weder S, Awwad HM, Sputtek A, Geisel J, Keller M. Vitamin B-12-fortified toothpaste improves vitamin status in vegans: a 12-wk randomized placebo-controlled study. Am J Clin Nutr. 2017 Mar;105(3):618-625. doi: 10.3945/ajcn.116.141978. Epub 2017 Jan 4.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
December 1, 2015
Study Registration Dates
First Submitted
February 8, 2016
First Submitted That Met QC Criteria
February 9, 2016
First Posted (Estimate)
February 10, 2016
Study Record Updates
Last Update Posted (Actual)
May 11, 2018
Last Update Submitted That Met QC Criteria
May 7, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- B12 status after toothpaste
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
Data sharing only between the two responsible study centers in a coded form, where participant ID is not shared.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cobalamin Deficiency
-
Haukeland University HospitalCompletedBiochemical Cobalamin Status | Motor NeurodevelopmentNorway
-
Nutrition Institute, SloveniaEuropean Regional Development Fund; Vizera d.o.o.; Frutarom Etol d.o.o.CompletedVitamin B 12 Deficiency | Vitamin d Deficiency | Protein DeficiencySlovenia
-
Washington University School of MedicineUniversity of California, Davis; Universidad San Francisco de Quito; Pan American...CompletedCholine Deficiency | Vitamin B-12 Deficiency | Lipids Deficiency | Amino Acids DeficiencyEcuador
-
SourseCitruslabsCompletedMood | Energy Supply; Deficiency | B12 Deficiency VitaminUnited States
-
University of California, DavisUniversity of California, San Francisco; University of Rhode Island; Ethiopian... and other collaboratorsCompletedVitamin B 12 Deficiency | Folate Deficiency | Iodine Deficiency | Anemia Deficiency | Salt Intake | Anemia MacrocyticEthiopia
-
ProofPilotJoovvUnknownTestosterone Deficiency | Estrogen DeficiencyUnited States
-
Meir Medical CenterCompletedFolic Acid Deficiency | Vitamin B12 DeficiencyIsrael
-
University Medical Centre LjubljanaCompletedBody Weight | IVF | Nutrient Deficiency | Dietary Vitamin B12 Deficiency Anemia | Dietary Folate Deficiency AnemiaSlovenia
-
Quadram Institute BioscienceNorfolk and Norwich University Hospitals NHS Foundation TrustEnrolling by invitationIron Deficiency (Without Anemia) | B12 Deficiency VitaminUnited Kingdom
-
Nutrition Institute, SloveniaNational Institute of Public Health, Slovenia; University Medical Centre LjubljanaCompletedThyroid Diseases | Iron-deficiency | Vitamin D Deficiency | Nutritional Status | Vitamin B 12 Deficiency | Folic Acid Deficiency | Diet | Nutrient Deficiency | Micronutrient DeficiencySlovenia
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AkesoNot yet recruitingAtopic DermatitisChina
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of